Soldini, Davide; Gaspert, Ariana; Montani, Matteo; Reineke, Tanja; Rogler, Gerhard; Odze, Robert; Weber, Achim (2014). Apoptotic enteropathy caused by antimetabolites and TNF-α antagonists. Journal of clinical pathology, 67(7), pp. 582-586. BMJ Publishing Group 10.1136/jclinpath-2014-202199
Text
J Clin Pathol-2014-Soldini-582-6.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (416kB) |
AIMS
To investigate whether drugs others than mycophenolic acid and ipilimumab might cause graft-versus-host-like apoptotic enteropathy, the clinicopathological findings in four patients were examined who had developed watery diarrhoea and apoptotic enteropathy (three cases from colon and one case from ileal pouch) after intake of antimetabolites (methotrexate and capecitabine) and/or tumour necrosis factor-α inhibitors (etanercept and infliximab).
METHODS
The clinical charts, endoscopy reports and intestinal biopsies from all endoscopies were reviewed for all patients. Biopsies were evaluated semiquantitatively for apoptosis of basal crypts, dilated damaged crypts, defined as cystically dilated crypts with flattened degenerated epithelium containing apoptotic debris and few neutrophils, and mucosal architecture. Further, the presence of intraepithelial lymphocytes, chronic inflammatory cells in the lamina propria and mucosal ulcerations was recorded and immunohistochemical analysis for human cytomegalovirus and herpes simplex virus was performed.
RESULTS
Endoscopic examination revealed normal mucosa in two patients, whereas the other two showed focal ulcerations. Histological changes included increased apoptosis of basal crypts, the presence of dilated damaged crypts and architecture distortion. In all cases, a temporal association between drug intake and/or dose increase, and onset of diarrhoea, was observed, and no convincing evidence of other potentially underlying causes of colitis/enteritis was found, including infections.
CONCLUSIONS
Pathologists should be aware of the expanding spectrum of drugs that can cause apoptotic enteropathy, including antimetabolites and tumour necrosis factor-α inhibitors.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology |
UniBE Contributor: |
Montani, Matteo |
ISSN: |
0021-9746 |
Publisher: |
BMJ Publishing Group |
Language: |
English |
Submitter: |
Doris Haefelin |
Date Deposited: |
23 Feb 2015 11:23 |
Last Modified: |
05 Dec 2022 14:41 |
Publisher DOI: |
10.1136/jclinpath-2014-202199 |
PubMed ID: |
24723128 |
Uncontrolled Keywords: |
Apoptosis, Diagnostics, Gastroenterology |
BORIS DOI: |
10.7892/boris.63559 |
URI: |
https://boris.unibe.ch/id/eprint/63559 |